{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:40:33Z","timestamp":1720759233923},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12029-018-0155-7","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T03:30:49Z","timestamp":1541561449000},"page":"907-912","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran"],"prefix":"10.1007","volume":"50","author":[{"given":"Farshid","family":"Farhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Ghalehtaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Mahdavi-Seresht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alipasha","family":"Meysamie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maisa","family":"Yamrali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borna","family":"Farazmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Saraee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Lashkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Salarvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Esmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Samiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"issue":"5","key":"155_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277\u2013300.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"155_CR2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006 May;24(14):2137\u201350. https:\/\/doi.org\/10.1200\/JCO.2005.05.2308.","journal-title":"J Clin Oncol"},{"issue":"3","key":"155_CR3","first-page":"125","volume":"4","author":"A Aledavood","year":"2011","unstructured":"Aledavood A, Anvari K, Sabouri G. Esophageal cancer in northeast of Iran. Iran J Cancer Prev. 2011;4(3):125\u20139.","journal-title":"Iran J Cancer Prev"},{"issue":"3","key":"155_CR4","first-page":"595","volume":"11","author":"M Babaei","year":"2010","unstructured":"Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, et al. Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev. 2010;11(3):595\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21039022","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"155_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/dote\/9.3.173","volume":"9","author":"JR Siewert","year":"1996","unstructured":"Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction - classification, pathology and extent of resection. Dis Esophagus. 1996;9(3):173\u201382. https:\/\/doi.org\/10.1093\/dote\/9.3.173.","journal-title":"Dis Esophagus"},{"issue":"7","key":"155_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1245\/ASO.2004.10.026","volume":"11","author":"R Iyer","year":"2004","unstructured":"Iyer R, Wilkinson N, Demmy T, Javle M. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol. 2004;11(7):665\u201373.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"155_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681\u201392. https:\/\/doi.org\/10.1016\/S1470-2045(11)70142-5.","journal-title":"Lancet Oncol"},{"issue":"6","key":"155_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","volume":"185","author":"JD Urschel","year":"2003","unstructured":"Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185(6):538\u201343.","journal-title":"Am J Surg"},{"issue":"22","key":"155_CR9","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, BPL W, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1112088.","journal-title":"N Engl J Med"},{"issue":"23","key":"155_CR10","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","volume":"32","author":"C Mariette","year":"2014","unstructured":"Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416\u201322.","journal-title":"J Clin Oncol"},{"issue":"14","key":"155_CR11","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1200\/JCO.2004.01.015","volume":"22","author":"JA Ajani","year":"2004","unstructured":"Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, et al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004;22(14):2774\u201380.","journal-title":"J Clin Oncol"},{"issue":"6","key":"155_CR12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1200\/JCO.2005.01.305","volume":"23","author":"JA Ajani","year":"2005","unstructured":"Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, et al. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol. 2005;23(6):1237\u201344.","journal-title":"J Clin Oncol"},{"issue":"24","key":"155_CR13","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1200\/JCO.2006.06.4840","volume":"24","author":"JA Ajani","year":"2006","unstructured":"Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PWT, Crane CH, et al. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol. 2006;24(24):3953\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"155_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/mco.2013.89","volume":"1","author":"M Motoori","year":"2013","unstructured":"Motoori M, Yano M, Yasuda T, Miyata H, Peng Y, Yamasaki M, et al. Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapy. Mol Clin Oncol. 2013;1(3):521\u20136. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3916104&tool=pmcentrez&rendertype=abstract","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"155_CR15","first-page":"11","volume":"1","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Nimeiri HS, Benson AB. Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer? Ann Transl Med. 2013;1(2):11\u20136. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4200631&tool=pmcentrez&rendertype=abstract","journal-title":"Ann Transl Med"},{"issue":"9319","key":"155_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","volume":"359","author":"Group MRCOCW","year":"2002","unstructured":"Group MRCOCW. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12049861","journal-title":"Lancet"},{"issue":"6","key":"155_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","volume":"27","author":"M Stahl","year":"2009","unstructured":"Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27(6):851\u20136.","journal-title":"J Clin Oncol"},{"key":"155_CR18","doi-asserted-by":"crossref","unstructured":"Walsh T et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. 1996;","DOI":"10.1056\/NEJM199608153350702"},{"issue":"2","key":"155_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","volume":"19","author":"SG Urba","year":"2001","unstructured":"Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001 Jan;19(2):305\u201313.","journal-title":"J Clin Oncol"},{"issue":"9","key":"155_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","volume":"6","author":"B Burmeister","year":"2005","unstructured":"Burmeister B, Smithers M, Gebski V, Denham J, Devitt P, Ackland S, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6(9):659\u201368.","journal-title":"Lancet Oncol"},{"key":"155_CR21","unstructured":"Akhavan A, Binesh F, Seifaddiny A. Characteristics and survival rate of patients with gastric and gastroesophageal junction adenocarcinoma in Yazd, Iran. 2013;4(3):125\u20139."},{"issue":"8","key":"155_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.4103\/1735-1995.168377","volume":"20","author":"K Anvari","year":"2015","unstructured":"Anvari K, Aledavood SA, Toussi MS, Forghani MN, Mohtashami S, Rajabi MT, et al. A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma. J Res Med Sci. 2015 Aug;20(8):751\u20136.","journal-title":"J Res Med Sci"},{"key":"155_CR23","unstructured":"Cellini F, Fiore M, Mattiucci G. Gastrointestinal & digestive system radiochemotherapy in the management of gastroesophageal junction tumours: basic evidences in the neoadjuvant setting. 2013;3(4):3\u20136."},{"issue":"7","key":"155_CR24","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008 Mar;26(7):1086\u201392.","journal-title":"J Clin Oncol"},{"issue":"13","key":"155_CR25","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouch\u00e9 O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321.","journal-title":"J Clin Oncol"},{"issue":"4","key":"155_CR26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1754-9485.12190","volume":"58","author":"YY Soon","year":"2014","unstructured":"Soon YY, Leong CN, Tey JCS, Tham IWK, Lu JJ. Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis. J Med Imaging Radiat Oncol. 2014;58(4):483\u201396.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"155_CR27","doi-asserted-by":"crossref","unstructured":"Sun L, Zhao G, Ding D, Song B, Hou R, Li Y. Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective , comparative study at a single tertiary care institute. 2014;1\u20135.","DOI":"10.1186\/1477-7819-12-280"},{"key":"155_CR28","doi-asserted-by":"crossref","unstructured":"Mirza A, Pritchard S, Welch I. The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas. Int J Surg Oncol. 2013;2013","DOI":"10.1155\/2013\/781742"},{"issue":"5","key":"155_CR29","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1007\/s13277-014-1653-2","volume":"35","author":"LL Li","year":"2014","unstructured":"Li LL, Xie CY, Su HF. Benefit of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis. Tumor Biol. 2014;35(5):4957\u201366.","journal-title":"Tumor Biol"},{"issue":"4","key":"155_CR30","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3892\/ol.2014.2382","volume":"8","author":"YJ Zhai","year":"2014","unstructured":"Zhai YJ, Su YP, Wang SJ, Ning FL, Wang ZB, Yu WZ, et al. A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy. Oncol Lett. 2014;8(4):1844\u20138.","journal-title":"Oncol Lett"},{"issue":"1","key":"155_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa055531.","journal-title":"N Engl J Med"},{"issue":"18_suppl","key":"155_CR32","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1200\/jco.2007.25.18_suppl.4510","volume":"25","author":"V Boige","year":"2007","unstructured":"Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouch\u00e9 O, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)\/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol. 2007;25(18_suppl):4510. https:\/\/doi.org\/10.1200\/jco.2007.25.18_suppl.4510.","journal-title":"J Clin Oncol"},{"issue":"18_suppl","key":"155_CR33","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1200\/jco.2007.25.18_suppl.4512","volume":"25","author":"PG Thirion","year":"2007","unstructured":"Thirion PG, Michiels S, Le Ma\u00eetre A, Tierney J. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. J Clin Oncol. 2007;25(18_suppl):4512. https:\/\/doi.org\/10.1200\/jco.2007.25.18_suppl.4512.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-018-0155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-018-0155-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-018-0155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:26:39Z","timestamp":1720758399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-018-0155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1007\/s12029-018-0155-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"7 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}